The Center for Biologics Evaluation & Research intramural research programs in vaccines will be the subject of a Nov. 18 meeting of FDA’s Vaccines & Related Biological Products Advisory Committee.

The committee will hear about research programs in the Office of Vaccines Research & Review’s Laboratory of Enteric and Sexually Transmitted Diseases.

The meeting will be held as a teleconference conference call from 1 p.m. to 3:30 p.m. The public may listen to the call in Building 29B Conference Room C on the National Institutes of Health’s main campus in Bethesda, Md.

The meeting will be closed from 3-3:30 p.m. to permit discussion where disclosure would constitute a clearly unwarranted invasion of privacy.